Amring Pharmaceuticals Inc.
Amring Pharmaceuticals Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a focus on therapeutic areas such as pain management and infectious diseases, Amring is dedicated to providing innovative solutions that meet the evolving needs of healthcare providers and patients. The company’s core products include a range of injectable medications, which are distinguished by their rigorous quality standards and commitment to safety. Amring's strategic operational regions extend across North America, allowing it to effectively serve a diverse market. Notable achievements include securing FDA approvals for several key products, reinforcing its position as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Amring Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amring Pharmaceuticals Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Amring Pharmaceuticals Inc.'s reported carbon emissions
Amring Pharmaceuticals Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. Additionally, the company has not outlined any formal reduction targets or climate pledges, which limits the ability to assess their commitments towards climate action. In the absence of specific emissions data and reduction initiatives, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and carbon footprint reduction. This trend often includes setting science-based targets and engaging in initiatives aimed at minimising environmental impact. As the industry evolves, it will be crucial for Amring Pharmaceuticals to establish clear climate commitments to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amring Pharmaceuticals Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
